Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment

Virology
A ZibertM Roggendorf

Abstract

It has been postulated that antibodies specific to the hypervariable region 1 (HVR1) within the putative envelop protein E2 of hepatitis C virus (HCV) can neutralize virus. We studied such antibodies in sera of patients who were infected in a single-source outbreak by a contaminated anti-D immunoglobulin preparation (HCV-AD78). The nucleotide sequences of cDNAs encoding HVR1 of HCV-AD78 were determined. The four major variants (HVR1.A, B, C, and D) were expressed as fusion proteins in Escherichia coli. Sixty-seven percent of sera contained antibodies to HVR1.A. Sera unrelated to infection of the outbreak also recognized HVR1.A but to a lesser extent (15%), suggesting that not all HVR1-specific antibodies are absolutely isolate-specific. Antibodies directed against individual variants of HVR1 were found in sera obtained early postinfection (p.i.) (< or = 1 year) but also in sera obtained several years later. An in vitro binding assay of HCV to tissue culture cells was employed to further characterize these sera. Five of seven sera that were obtained early p.i. prevented binding of HCV to cells. Preincubation of such sera with HVR1-specific fusion proteins restored binding of HCV to cells in four of five sera. These findings sugg...Continue Reading

Citations

Apr 12, 2000·Journal of Viral Hepatitis·D B Smith
Mar 21, 2002·Immunology and Cell Biology·A J FreemanA R Lloyd
Jan 10, 2003·Journal of Gastroenterology and Hepatology·Mina SasakiNaoaki Hayashi
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·P FarciR H Purcell
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·D RosaS Abrignani
Jan 1, 1995·Journal of Viral Hepatitis·N Enomoto, C Sato
Feb 7, 2001·Clinical Microbiology Reviews·N N Zein
Apr 26, 2005·Virology Journal·Stephen J PolyakUNKNOWN HALT-C Trial Group
Dec 14, 2011·Viruses·Yong WangSteven K H Foung
Sep 17, 2010·World Journal of Gastroenterology : WJG·Bing-Shui XiuHui-Ying Rao
Mar 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jean-Christophe MeunierJens Bukh
Nov 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Birke BartoschRobert H Purcell
Jun 29, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Henry PollackWilliam Borkowsky
Jun 10, 1998·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·F LunelG Maertens
Nov 29, 2005·Applied Bioinformatics·Karina YusimCarla Kuiken
Jan 1, 1997·Springer Seminars in Immunopathology·G Inchauspé
Jan 1, 1997·Springer Seminars in Immunopathology·C M Walker
Apr 1, 1996·Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·N Kato, K Shimotohno
Sep 28, 2002·Journal of Pediatric Gastroenterology and Nutrition·Ding-You Li, Kathleen B Schwarz
Jan 4, 2001·Microbes and Infection·D R TaylorM M Lai
Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M HattoriS Kakumu
Jul 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A SakaiK Kobayashi
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R BurioniM Clementi
Apr 1, 1997·Kidney International·B J Pereira, A S Levey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.